Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite (Nasdaq: CLBT) reported strong Q3 2021 results, with a revenue of $65.9 million, up 24% year-over-year. The company achieved a GAAP net income of $8.1 million and an Adjusted EBITDA of $15.0 million, reflecting a 22.8% margin. Subscription revenue rose 46% to $51.3 million, driving an annual recurring revenue (ARR) increase of 42% to $171 million. Cellebrite has raised its full-year revenue guidance to between $241.5 million and $243.5 million. The company continues to expand its digital intelligence solutions and completed a major acquisition.
Cellebrite (Nasdaq: CLBT) announced the release of an upgraded version of Cellebrite Guardian, a cloud-based digital evidence management system aimed at enhancing the investigative workflow for public safety agencies. The system addresses challenges of managing big data and streamlines evidence storage, sharing, and review, enabling faster resolutions of cases. Built on AWS GovCloud, it boasts enhanced security and cost-efficiency compared to manual systems. The platform is expected to be generally available in Q4 2021, reflecting Cellebrite's commitment to transforming digital investigation processes.
Cellebrite (Nasdaq: CLBT) announced on October 11, 2021 its definitive agreement to acquire Digital Clues AG, enhancing its Digital Intelligence solutions for law enforcement. The acquisition, expected to close in Q4 2021, aims to expand capabilities in open-source intelligence, which is crucial for initiating investigations. Digital Clues contributes SaaS and on-premise solutions powered by artificial intelligence, enriching investigative data. The move solidifies Cellebrite's aim to digitize the entire investigative workflow globally.
Cellebrite (Nasdaq: CLBT) announced the release of its third quarter 2021 financial results, scheduled for November 10, 2021, before the market opens. A conference call will be held at 8:30 a.m. ET on the same day, where management will discuss the financial outcomes. Cellebrite specializes in Digital Intelligence solutions for both public and private sectors, aiding in lawful digital investigations across over 140 countries. The company emphasizes its commitment to enhancing data handling for legal inquiries and promoting privacy.
Cellebrite (NASDAQ: CLBT) has launched a remote mobile data collection feature for its Endpoint Inspector, enhancing capabilities for e-discovery and corporate investigations. This solution uniquely retrieves evidence from iOS, Android devices, and computers, addressing the growing need for effective data collection amidst increasing remote work. The update simplifies the data collection process, allowing enterprises to efficiently gather critical information while maintaining employee privacy through consent mechanisms.
Cellebrite DI Ltd. (Nasdaq: CLBT) announced the establishment of an Ethics & Integrity Committee to guide its Board on ethical practices and compliance with international laws. This Committee aims to reinforce the company's commitment to responsible business operations. It will provide expertise on ethical sales practices, emerging technology regulations, and human rights issues. Comprised of notable experts, including members from prestigious institutions, this initiative seeks to enhance Cellebrite's transparency and stakeholder trust. CEO Yossi Carmil emphasized the importance of ethical conduct in fostering safe communities.